Am Pharma

Product Description

TIZARO (tirzepatide)  7.5 mg,  per 0.5 mL insulin, is a prescription medicine for adults with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose). It is not known if tizaro can be used in people who have had pancreatitis.

ALSO KNOWN TO HELP WITH WEIGHT LOSS

Product Description

TIZARO (tirzepatide)  2.5 mg,  per 0.5 mL insulin, is a prescription medicine for adults with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose). It is not known if tizaro can be used in people who have had pancreatitis.

ALSO KNOWN TO HELP WITH WEIGHT LOSS

Product Description

TIZARO (tirzepatide)  5 mg,  per 0.5 mL insulin, is a prescription medicine for adults with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose). It is not known if tizaro can be used in people who have had pancreatitis.

ALSO KNOWN TO HELP WITH WEIGHT LOSS

Arvast CV 10 Capsule should be taken with or without food. You should take it regularly at evenly spaced intervals as per the schedule prescribed by your doctor. Taking it at the same time every day will help you remember to take it. The dose and duration of treatment will depend on what you are being treated for. Do not stop taking it until you have finished the complete course, even when you feel better. Lifestyle changes like low-fat diet, exercise and not smoking may help this medicine to work better.

Semaglutide is a GLP-1 analogue with 94% sequence as same as human GLP-1. Semaglutide acts as a GLP-1 receptor agonist that selectively binds to and activates the GLP- receptor. GLP-1 is a physiological regulator of appetite and caloric intake. It is also present in several areas of brain that involved in appetite regulation. Semaglutide lowers body weight through decreased calorie intake and by an overall reduced appetite. It also stimulates insulin secretion and reduces glucagon secretion in a glucose dependent manner.

Indications An adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of :

30 kg/m2 or greater (Obesity) or

• 27 kg/m2 or greater (Overweight) in the presence of at least one weight-related comorbid condition (e.g. hypertension, type 2 diabetes mellitus or dyslipidemia).

Dosage & Administration The starting dose is 0.25 mg Semaglutide once weekly for 4 weeks subcutaneously. Then in 4 weeks intervals dose should be increased until a dose of 2.4 mg is reached. Patient should follow the dose escalation schedule given below.

Trulicity (dulaglutide) is commonly used to help lower blood sugar levels in people with type 2 diabetes. 

Trulicity is used to lower the risk of cardiovascular events (heart attack, stroke, or death) in people who have type 2 diabetes and heart disease.

Trulicity may also be used for other conditions as determined by your healthcare provider.

Erly (Liraglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat certain types of metabolic conditions, including type 2 diabetes and obesity. Liraglutide mimics the action of GLP-1, a hormone that helps regulate blood sugar, promotes satiety (feeling of fullness), and reduces appetite.

1. Type 2 Diabetes (Diabetes Mellitus)

   • Erly (Liraglutide) is used as a once-daily injection to improve blood sugar control in adults with type 2 diabetes, especially in combination with diet and exercise.
   • It works by enhancing insulin secretion in response to meals and inhibiting excessive glucagon release (a hormone that increases blood sugar), thus helping lower blood glucose levels.

2. Obesity and Overweight Management

   • Liraglutide is prescribed under the brand name Saxenda for weight management in adults and children aged 12 years and older who have obesity or are overweight with weight-related comorbidities (e.g., hypertension, type 2 diabetes).
   • It promotes weight loss by reducing appetite and increasing feelings of fullness, making it easier for individuals to adhere to a reduced-calorie diet.

Liraglutide is a synthetic version of GLP-1, a hormone that naturally occurs in the body. It acts on several mechanisms:

• Increased Insulin Secretion: Enhances insulin release from the pancreas in response to meals (helps lower blood glucose).
• Reduced Glucagon Secretion: Lowers glucagon (a hormone that raises blood glucose) production, leading to reduced hepatic glucose production.
• Slows Gastric Emptying: Slows down the emptying of food from the stomach, helping people feel full for longer periods and thus promoting weight loss.
• Appetite Reduction: Acts on the brain's appetite centers, reducing hunger and helping with weight management.

• For Type 2 Diabetes:
  • Starting dose: 0.6 mg once daily for one week.
  • Maintenance dose: 1.2–1.8 mg once daily, adjusted based on individual tolerance.
• For Obesity/Weight Management:
  • Starting dose: 0.6 mg once daily, gradually increased every week to the maintenance dose of 3 mg once daily.
  • Saxenda for weight loss is specifically available at higher concentrations (3 mg).
• Administration: Liraglutide is administered as a subcutaneous injection, typically in the abdomen, thigh, or upper arm.

1. Gastrointestinal Issues

   • Nausea (most common), vomiting, diarrhea, and constipation are common during the first few weeks of treatment. These side effects usually diminish over time.

2. Appetite Suppression

   • Reduced appetite may help with weight loss, but it can also cause reduced interest in food, leading to possible unintentional weight loss in some individuals.

3. Injection Site Reactions

   • Pain, redness, or swelling at the injection site.

4. Headache

   • Some people may experience headaches, especially when starting treatment.

5. Fatigue

   • Tiredness and fatigue are relatively common, particularly in the early stages of treatment.

1. Pancreatitis

   • Liraglutide can increase the risk of pancreatitis (inflammation of the pancreas). Signs include severe abdominal pain, nausea, and vomiting. Immediate medical attention is necessary if these symptoms occur.

3ml Erly Liraglutide Injection contains liraglutide, a medication used primarily in the treatment of type 2 diabetes and obesity. It is a GLP-1 receptor agonist that helps regulate blood sugar levels and can also aid in weight loss. The primary uses of liraglutide include:

1. Type 2 Diabetes Management: Liraglutide is used to improve blood sugar control in adults with type 2 diabetes. It works by stimulating insulin release in response to meals, inhibiting glucagon release, and slowing gastric emptying to help lower blood glucose levels after meals.

2. Obesity Management: Liraglutide is used as part of a weight management regimen in adults with obesity or those who are overweight with comorbid conditions (e.g., hypertension, type 2 diabetes, high cholesterol). It helps with weight loss by decreasing appetite, increasing feelings of fullness, and promoting lower calorie intake.

3. Cardiovascular Risk Reduction: In people with type 2 diabetes who have existing cardiovascular disease, liraglutide has been shown to reduce the risk of heart attack, stroke, and cardiovascular death.

4. Non-Alcoholic Fatty Liver Disease (NAFLD): Liraglutide may be used off-label in some cases to help reduce fat accumulation in the liver in patients with non-alcoholic fatty liver disease, particularly in people with type 2 diabetes.

Liraglutide is typically administered via subcutaneous injection once a day. The dosage may vary depending on the condition being treated and the patient's response.

Common side effects of liraglutide include nausea, vomiting, diarrhea, headaches, and potential risk of pancreatitis. It may also cause a slight increase in heart rate, and in rare cases, thyroid tumors. It is important to use liraglutide under the supervision of a healthcare provider, especially for people with a history of thyroid cancer or pancreatitis.

Common indications for Lirafit Solution for Injection include:

• Diabetes Management: Used to improve glycemic control in adults with type 2 diabetes mellitus.

Packaging:
Lirafit Solution for Injection is typically packaged in a pre-filled pen or vial, making it convenient for patients to administer the medication at home.

Lirafit Solution for Injection is an important therapeutic option for managing type 2 diabetes mellitus, particularly in patients who have not achieved adequate blood glucose control with oral antidiabetic agents. Due to the potential for side effects, including serious ones like pancreatitis, treatment with Liraglutide should be overseen by a healthcare professional. Regular monitoring of the patient’s blood glucose levels and overall health is essential during therapy.

Prandial 0.3 MD Tablet is a medicine used to treat type 2 diabetes mellitus. It helps control the high blood sugar levels in your body after each meal. It is used when other similar medicines along with a restricted diet, are unable to control abnormally high blood sugar levels.

0.75 mg Dulaglutide Injection is a medication used primarily for the treatment of type 2 diabetes. Dulaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the action of a natural hormone in the body to help control blood sugar levels.

1. Management of Type 2 Diabetes:

   • Dulaglutide is used in the treatment of type 2 diabetes mellitus to improve blood sugar control. It works by mimicking the action of GLP-1, a hormone that the body releases in response to food intake. The drug helps to increase insulin secretion when blood sugar levels are high, reduce the amount of sugar released by the liver, and slow down gastric emptying, which helps regulate blood sugar levels and reduces after-meal spikes.
   • It is often used in combination with other antidiabetic medications, such as metformin, for better blood sugar management.

2. Reduction of Hemoglobin A1c (HbA1c):

   • Dulaglutide has been shown to effectively reduce HbA1c levels, which is a marker of long-term blood sugar control. It helps patients achieve and maintain the target HbA1c level, thereby reducing the risk of complications related to diabetes.

3. Weight Loss (in Type 2 Diabetes):

   • In addition to lowering blood sugar, Dulaglutide has been associated with weight loss in people with type 2 diabetes. It helps reduce appetite and promotes satiety (feeling of fullness), which can lead to a decrease in overall food intake and help with weight management.

4. Cardiovascular Benefits:

   • Dulaglutide has been shown to provide cardiovascular benefits in patients with type 2 diabetes, particularly in those with established heart disease or at high risk for cardiovascular events. Studies have shown that it may reduce the risk of major cardiovascular events, such as heart attack, stroke, and cardiovascular death in certain patients.

5. Improvement of Insulin Sensitivity:

   • By stimulating insulin production in response to elevated blood sugar levels, Dulaglutide helps to improve insulin sensitivity. This means the body uses insulin more effectively, reducing the need for high amounts of insulin to manage blood glucose levels.